Trials / Completed
CompletedNCT00363233
The Potential Effects and Mechanisms of Flax Lignans on Type 2 Diabetes Mellitus
The Effects of Flax Lignans on Lipid Profile and Glucose Management in Type 2 Diabetes: a Randomized Double-Blind Cross-Over Study
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 80 (planned)
- Sponsor
- Chinese Academy of Sciences · Other Government
- Sex
- All
- Age
- 50 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to improving the lipid profile and glucose control in type 2 diabetic patients with supplementation of flax lignans. We hypothesize that flax lignans supplement will improve the cholesterol profile and glucose control in type 2 diabetic patients.
Detailed description
The prevalence of type 2 diabetes is increasing dramatically in the last decade in China. Hyperlipidemia is a comorbid condition in type 2 diabetes and increase the adverse health outcomes. Flax lignans, a phytoestrogen found in flaxseed is thought to be the compound responsible for cholesterol-lowering effect of flaxseed. Our purpose is to improving the lipid profile in type 2 diabetic patients with supplementation of flax lignans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | flax lignans |
Timeline
- Start date
- 2006-03-01
- Completion
- 2006-12-01
- First posted
- 2006-08-15
- Last updated
- 2007-01-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00363233. Inclusion in this directory is not an endorsement.